No. J7626 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code.

What NDCs are billed under J7626?

CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 38 NDCs under J7626, for Budesonide and Pulmicort. The table on this page shows each one with its billing units per package.

What is the Medicare payment limit for J7626?

$0.923 per 0.5 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

J7626 J-Code: Pulmicort (budesonide) — Billing Units

In short

J7626 is the HCPCS Level II code for budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg. CMS assigns NDCs for Budesonide and Pulmicort to it. The Medicare Part B payment limit is $0.923 per unit (October 1, 2026 through December 31, 2026).

Code

CMS HCPCS file

HCPCS codeJ7626

Billing unitSee descriptor

Descriptor: Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
Short descriptor: Budesonide non-comp unit
Code set: HCPCS Level II, maintained by CMS
Effective: Jan 1, 2007

Medicare Part B payment limit

CMS ASP file

Payment limit per unit$0.923

Per0.5 mg

Coinsurance20%

Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files

Units and claim line

Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

HCPCS units

Modifier

NDC (11-digit)

NDC unit qualifier

NDC quantity

Enter the units to build the claim line.

NDCs billed under J7626

CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 38 NDCs to J7626 for Budesonide and Pulmicort. Billing units per package are CMS’s figures for this code’s unit.

NDCs assigned to J7626 in the CMS ASP crosswalk
Drug	NDC (11-digit)	Labeler	Package	Billing units per package
Budesonide	00093-6815-55	Teva Pharmaceuticals USA, Inc.	30 × 2	30
Budesonide	00093-6815-73	Teva Pharmaceuticals USA, Inc.	30 × 2	30
Budesonide	00093-6816-55	Teva Pharmaceuticals USA, Inc.	30 × 2	30
Budesonide	00093-6816-73	Teva Pharmaceuticals USA, Inc.	30 × 2	30
Budesonide	00093-6817-73	Teva Pharmaceuticals USA, Inc.	30 × 2	60
Budesonide	00115-1687-74	Impax Laboratories, LLC	30 × 2	30
Budesonide	00115-1689-74	Impax Laboratories, LLC	30 × 2	30
Budesonide	00487-9601-01	Nephron SC, Inc.	30 × 2	30
Budesonide	00487-9601-30	Nephron SC, Inc.	30 × 2	30
Budesonide	00487-9701-01	Nephron SC, Inc.	30 × 2	30
Budesonide	00487-9701-30	Nephron SC, Inc.	30 × 2	30
Budesonide	16714-0020-30	Northstar RxLLC	30 × 2	60
Budesonide	47335-0631-49	Sun Pharmaceutical Global FZE.	30 × 2	30
Budesonide	47335-0632-49	Sun Pharmaceutical Global FZE.	30 × 2	30
Budesonide	47335-0633-49	Sun Pharmaceutical Global FZE.	30 × 2	60
Budesonide	50090-1467-00	A-S Medication Solutions	30 × 2	30
Budesonide	50090-6586-00	A-S Medication Solutions	30 × 2	30
Budesonide	50090-6590-00	A-S Medication Solutions	30 × 2	30
Budesonide	50090-7126-00	A-S Medication Solutions	30 × 2	30
Budesonide	50090-7173-00	A-S Medication Solutions	30 × 2	30
Budesonide	60687-0524-83	American Health Packaging	30 × 2	30
Budesonide	62135-0822-84	Chartwell	30 × 2	30
Budesonide	62135-0823-84	Chartwell	30 × 2	30
Budesonide	64980-0638-03	Rising Pharma Holdings, Inc.	30 × 2	30
Budesonide	64980-0639-03	Rising Pharma Holdings, Inc.	30 × 2	30
Budesonide	68180-0984-30	Lupin Pharmaceuticals, Inc.	30 × 2	30
Budesonide	69097-0318-53	Cipla USA, Inc.	30 × 2	30
Budesonide	69097-0318-87	Cipla USA, Inc.	30 × 2	30
Budesonide	69097-0319-53	Cipla USA, Inc.	30 × 2	30
Budesonide	69097-0319-87	Cipla USA, Inc.	30 × 2	30
Budesonide	69097-0321-53	Cipla USA, Inc.	30 × 2	60
Budesonide	69097-0321-87	Cipla USA, Inc.	30 × 2	60
Budesonide	76204-0018-01	Ritedose Pharmaceuticals, LLC	30 × 2	30
Budesonide	76282-0640-38	Exelan Pharmaceuticals, Inc.	30 × 2	30
Budesonide	76282-0641-38	Exelan Pharmaceuticals, Inc.	30 × 2	30
Pulmicort	00186-1988-04	AstraZeneca Pharmaceuticals LP	30 × 2	30
Pulmicort	00186-1989-04	AstraZeneca Pharmaceuticals LP	30 × 2	30
Pulmicort	00186-1990-04	AstraZeneca Pharmaceuticals LP	30 × 2	60

J7626: common questions

Is J7626 a CPT code?: No. J7626 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What NDCs are billed under J7626?: CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 38 NDCs under J7626, for Budesonide and Pulmicort. The table on this page shows each one with its billing units per package.
What is the Medicare payment limit for J7626?: $0.923 per 0.5 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

J7626 — Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg